Cephalosporin susceptibility of Staphylococcus aureus strains isolated from commercial rabbit and goats farms in Spain
DOI:
https://doi.org/10.12834/VetIt.2241.16176.1Keywords:
Cephalosporins, Staphylococcus aureus, Minimum inhibitory concentration (MIC), GoatsAbstract
Antimicrobial drug resistance is an important problem that challenges veterinary clinicians to provide effective treatments without further spreading resistance to other animals and people. The most commonly used pharmacodynamic parameter to define potency of antimicrobial drugs is minimum inhibitory concentration (MIC). The aim of this study was to evaluate the antibiotic susceptibility of thirty-six strains of Staphylococcus aureus isolated from dairy goats with mastitis and rabbits with chronic staphylococcosis. Four cephalosporins were tested: cephalexin, cephalotin, cefonicid and ceftiofur. MIC tests were performed according to the microdilution broth method. The calculated values of sensitivity in goats and rabbits were 66.67% and 72.22% for cephalexin, 72.22 % and 94.44% for cefonicid, 77.78% and 94.44% for cephalotin and 77.78% and 100% for ceftiofur, respectively. For all antibiotics, MIC90 of S. aureus from rabbits were lower than MIC90 from goats. These data suggest that more antibiotics are used in goat milk production than in rabbit farming. According to MIC values obtained in this study, ceftiofur and cephalotin may be the best option for treating S. aureus infections in lactating goats. For rabbits, ceftiofur showed lowest MIC values, therefore, it could be an alternative to treatment the infections caused by S. aureus in this species.
References
Aires-de-Sousa M., Parente C.E., Vieira-da-Motta O., Bonna I.C., Silva D.A. & de Lencastre H. 2007. Characterization of Staphylococcus aureus isolates from buffalo, bovine, ovine, and caprine milk samples collected in Rio de Janeiro State, Brazil. Appl Environ Microbiol, 73, 3845–3849.
Badillo E., Escudero E., Hernandis V., Galecio J.S. & Marín P. 2020. Pharmacokinetics of cefonicid in lactating goats after intravenous, intramuscular and subcutaneous administration, and after a long-acting formulation for subcutaneous administration. J Vet Pharmacol Therap, 43(1), 50-56.
Barry A.L., Jones R. & Packer R.R. 1986. Antistaphylococcal activity of ceforanide and cefonicid in the presence of human serum. Antimicrob Agents Chemother, 29(1), 147-149.
Caprile K.A. 1988. The cephalosporin antimicrobial agents: a comprehensive review. J Vet Pharmacol Therap, 11, 1-32.
Chopra I., Hodgson J., Metcalf B. & Poste G. 1997. The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob Agents Chemother, 41(3), 497-503.
Clinical and Laboratory Standards Institute (CLSI). 2015.Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. 10th Edition. NCCLS document M07-A10. Clinical and Laboratory Standards Institute, Pennsylvania.
Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing (CLSI).2018. 28th Edition. NCCLS document M100. Clinical and Laboratory Standards Institute, Pennsylvania.
Doré E., Angelos J.A., Rowe J.D., Carlson J.L., Weizlich S.E., Kieu H.T. & Tell L.A. 2011. Pharmacokinetics of ceftiofur crystalline free acid after single subcutaneous administration in lactating and nonlactating domestic goats (Capra aegagrus hircus). J Vet Pharmacol Therap, 34(1), 25–30.
Drusano G.L. 2004. Antimicrobial pharmacodynamics: critical interactions of "bug and drugs". Nat Rev Microbiol, 2(4), 289-300.
Dzierzanowska D., Patzer J. & Jeljaszewicz J. 1982. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits. Infection, 10(3), S217-20.
European Medicines Agency (EMA). 2019. Categorisation of Antibiotics in the European Union. Answer to the Request from the European Commission for Updating the Scientific Advice on the Impact on Public Health and Animal Health of the Use of Antibiotics in Animals. European Medicines Agency, Amsterdam, The Netherlands.
Fernández-Varón E., Cárceles-García C., Serrano-Rodríguez J.M. & Cárceles-Rodríguez C.M. 2016. Pharmacokinetics (PK), pharmacodynamics (PD), and PK-PD integration of ceftiofur after a single intravenous, subcutaneous and subcutaneous-LA administration in lactating goats. BMC Vet Res, 12(1), 232.
Gardhouse S., Guzman D.S., Cox S., Kass P.H., Drazenovich T.L., Byrne B.A. & Hawkins M.G. 2017. Pharmacokinetics and safety of ceftiofur crystalline free acid in New Zealand White rabbits (Oryctolagus cuniculus). Am J Vet Res, 78(7), 796-803.
Hermans K., De Herdt P., Devriese L.A., Hendrickx W., Godard C. & Haesebrouck F. 1999. Colonisation of rabbits with Staphylococcus aureus in flocks with and without chronic staphylococcosis. Vet Microbiol, 67, 37-46.
De Jong A., Moyaert H., Simjee S., El Garch F., Haag-Diergarten S., Klein U., Ludwig C., Butty P., Richard-Mazet A., Rigaut D., Thiry J. & Thomas V. 2015. Antimicrobial susceptibility monitoring of mastitis pathogens isolated from acute cases of clinical mastitis in dairy cows across Europe: VetPath results. Int J Antimicrob Agents, 46, 13-20.
De Jong A., Thomas V., Simjee S., Moyaert H., El Garch F., Maher K., Morrissey I., Butty P., Klein U., Marion H., Rigaut D. & Vallé M. 2014. Antimicrobial susceptibility monitoring of respiratory tractpathogens isolated from diseased cattle and pigs acrossEurope: The VetPath study. Vet Microbiol, 172, 202-215.
Lacchini R., Rule R., García-Román A., Antonini A. & de Buschiazzo P. 2007. Influence of feed type on the pharmacokinetics of cephalothin administered to lactating goats. Arch Zootec, 56, 807-815.
Lindeman C.J., Portis E., Johansen L., Mullins L.M. & Stoltman G. A. 2013. Susceptibility to antimicrobial agents among bovine mastitis pathogens isolated from North American dairy cattle, 2002–2010. J Vet Diagn Invest, 25(5), 581–591.
Livermore D.M. 2000. Antibiotic resistance in staphylococci. Int J Antimicrob Agents, 16, S3-10.
Meneses M.L., Albarellos G. & Landoni M.F. 2013. Pharmacokinetics of Cephalexin after Intravenous and Single and Multiple Intramuscular Administration to Rabbit. Int J Vet Med: Res Rep, 2013, 898594.
Mørk T., Tollersrud T., Kvitle B., Jørgensen H.J. & Waage S. 2005. Comparison of Staphylococcus aureus genotypes recovered from cases of bovine, ovine, and caprine mastitis. J Clin Microbiol, 43, 3979–3984.
De Oliveira A.P., Watts J.L., Salmon S.A. & Aarestrup F.M. 2000. Antimicrobial Susceptibility of Staphylococcus aureus isolated from bovine mastitis in Europe and the United States. J Dairy Sci, 83(4), 855-862.
Papich M.G. & Lindeman C. 2018. Cephalexin susceptibility breakpoint for veterinary isoletes: Clinical Laboratory Standars Institute revision. J Vet Diagn Invest, 30(1), 113-120.
Seegers H., Fourichon C. & Beaudeau F. 2003. Production effects related to mastitis and mastitis economics in dairy cattle herds. Vet Res, 34, 475–491.
Segura P., Martínez J., Peris B., Selva L., Viana D., Penades J.R. & Corpa J.M. 2007. Staphylococcal infections in rabbits does on two industrial farms. Vet Record, 160(25), 869-872.
Virdis S., Scarano C., Cossu F., Spanu V., Spanu C., & De Santis E.P.L. 2010. Antibiotic Resistance in Staphylococcus aureus and Coagulase Negative Staphylococci Isolated from Goats with Subclinical Mastitis. Vet Med Int, 2010(2), 517060.
